Home
WELLS BIO

WELLS BIO Market Share Analysis for June 2026

WELLS BIO develops and manufactures in vitro diagnostic tests based on immunochemical, biochemical, and molecular diagnostic technology for early diagnosis of diseases.

Industry: N/A

Domainwellsbio.net

Year Founded2013

Employees51 - 200

Annual Revenue$2M - $5M

WELLS BIO

WELLS BIO (including company regionals)

wellsbio.net

See more website traffic and engagement information

WELLS BIO Revenue up to June 2026 is 2M - 5M

revenue generated by WELLS BIO top domains

WELLS BIO top domains revenue over 3 years

Revenue for WELLS BIO top domains

wellsbio.net2M - 5M

See more with Sales Intelligence

Total visits to WELLS BIO's top domains

Understand WELLS BIO market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

wellsbio.net22.4K

See more with Sales Intelligence

Avg. visit duration in WELLS BIO's top domains

Analyze WELLS BIO engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

wellsbio.net00:00:57

See more with Sales Intelligence

Avg. pageviews on WELLS BIO's top domains

See how WELLS BIO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

wellsbio.net8.42

See more with Sales Intelligence

WELLS BIO top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by WELLS BIO

These are the website technologies, by industry, used by WELLS BIO top domains

Content Management System (2)

WordPress

Advertising (1)

PubMatic

Mobile (1)

Meta Viewport

Multilingual (1)

Multilingual Support

News & Signals from WELLS BIO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsWellsbio is developing careUS COVID/Flu A&B Antigen Combo', a kit.'Wells Bio Co., Ltd.', a subsidiary of 'Access Bio', a global in vitro diagnostic company, is developing 'careUS(TM) COVID/Flu A&B Antigen Combo', a kit that can simultaneously diagnose COVID-19 virus and type A and B influenza viruses.

NewsAccessbio partners with Wellsbio.These two options are developed by AccessBio, a reputable US-based firm specializing in early diagnostics, in collaboration with subsidiary Wells Bio.